Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Value, Access and Regulatory Strategy Workshop
Session 1: Different Perspectives on Unmet Medical Need
Session Chair(s)
Claudine Sapède, PharmD
- Director, Global HTA Policy
- Novartis Pharma AG, Switzerland
Speaker(s)
A Patient’s Perspective
François Houyez
- Information and Access Director, Health Policy Advisor
- European Organisation for Rare Diseases (EURORDIS), France
A Regulator’s Perspective
Michael Berntgen, PhD
- Head of Scientific Evidence Generation
- European Medicines Agency, Netherlands
An HTA Body’s Perspective
Antje Behring, PharmD, PhD
- Head, Early Benefit Assessment, Pharmaceuticals Department
- Federal Joint Committee (G-BA), Germany